Visual evaluation of one bupivacaine ampule from the returned tray found no visible non-conformities.The drug liquid was found to be clear (colorless) with no particulates visible inside the vial.Review of device history records and incoming records found no discrepancies or anomalies relevant to the complaint.Assay testing, performed by the supplier prior to release of bupivacaine lot # 62-312-ev, was within specification.Smith medical monitors supplied drug components stability post ethylene oxide sterilization throughout their expiry.Our records review found that the supplied drugs components continue to meet potency specifications.Complaint history review does not indicate any trends for the drug lot number, reported in this complaint.The anesthetic is a supplied item and the complaint notification was forwarded to the supplier.
|